bioRxivNeurosciencePreprint
A CK2α-G3BP1 signaling axis regulates local translation in developing neurons and is disrupted in OCNDS
Manasi AgrawaliD, Meghal DesaiiD, Shruti GhumraiD, Yashashree BhorkariD, Brandon J. VaglioiD, Kyle StokesiD, Krishna Rana, Ny-Ziah Hamilton Hill, Peace Nweze, Nethra Sriram, Alana LoRe, Riki KawaguchiiD, Bonnie L. FiresteiniD, Jack M. ParentiD, Daniel H. GeschwindiD, Heike RebholziD, Pabitra Kumar SahooiD
Abstract
Neurodevelopmental disorders are frequently caused by mutations in pleiotropic kinases, yet downstream effectors driving neuronal pathology remain undefined. Here, we identify the G3BP1-dependent stress granule pathway as the dominant effector of casein kinase 2 (CK2) in developing neurons, implying that its dysregulation underlies the neurodevelopmental deficits of Okur-Chung neurodevelopmental syndrome (OCNDS). OCNDS-associated CK2 mutations reduce phosphorylation of G3BP1 at serine 149, promoting aberrant phase separation and persistent granules that sequester neuronal mRNAs and suppress local protein synthesis across axonal and dendritic compartments. These phenotypes produce allele-specific deficits in neuronal morphogenesis, synaptic abundance, and network excitability, which are conserved in a knock-in mouse model and in patient-derived iPSC neurons. G3bp1 knockdown rescues translational and morphological phenotypes across all OCNDS alleles, demonstrating that restoring granule homeostasis reverses neuronal pathology. Together, these findings establish OCNDS as a disorder of compartment-specific translational dysregulation driven by impaired CK2-G3BP1 control of RNA granule homeostasis. SummaryOCNDS mutations disrupt CK2-G3BP1 signaling, causing persistent granules and defective neuronal translation and development.
- organism: human
- organism: mouse
- assay: proteomics
- research focus: cell type annotation
- research focus: differential expression
- research focus: gene regulatory network inference
- research focus: drug response / drug discovery
- approach: statistical model
- approach: experimental assay
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- The Okur-Chung Neurodevelopmental Syndrome (OCNDS) mutation CK2K198R leads to a rewiring of kinase specificity
Danielle Caefer, Nhat Q. Phan, … Daniel Schwartz·Frontiers in Molecular BiosciencesPeer-reviewed·Apr 19, 2022
- Druggable CSNK2A1-MeCP2 regulatory axis links Okur-Chung neurodevelopmental syndrome with MECP2-related disorders
Ashley G. Anderson, Srinivas Chamakuri, … Huda Y Zoghbi·bioRxiv·Nov 6, 2026
- Missense mutation in the activation segment of the kinase CK2 models Okur Chung neurodevelopmental disorder and alters the hippocampal glutamatergic synapse
Jose Manuel Cruz-Gamero, Demetra Ballardin, … Heike Rebholz·Molecular PsychiatryPeer-reviewed·Oct 4, 2024
- Impaired KCC2 phosphorylation leads to neuronal network dysfunction and neurodevelopmental pathogenesis.
Lucie Isoline Pisella, Jean‐Luc Gaïarsa, … Igor Medina·Science SignalingPeer-reviewed·Oct 15, 2019
- CK2 variant function and disease modelling in Drosophila reveal allelic heterogeneity and Wnt/β-catenin-mediated phenotypes
Yina Her, Danielle M. Pascual, … Paul C. Marcogliese·bioRxiv·Aug 21, 2026
- Characterizing CSNK2A1 Mutant-Induced Morphological Phenotypes in Zebrafish (Danio rerio): Insights into Okur-Chung Neurodevelopmental Syndrome (OCNDS)
Katie Hassett, Sai Srihaas Potu, … Sampathkumar Rangasamy·bioRxiv·Jan 9, 2024